Century Therapeutics, Inc. (IPSC) vs Palisade Bio, Inc. (PALI)
A side-by-side comparison of Century Therapeutics, Inc. and Palisade Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IPSC
Century Therapeutics, Inc.
$1.37HealthcareDelayed quote: Oct 6, 2026, 2:17 PM EDT
PALI
Palisade Bio, Inc.
$1.51HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — IPSC vs PALI
growth of $100 · dividends reinvested · last 5yIPSC -93.5% (-42.1%/yr)PALI -100.0% (-78.5%/yr)IPSC compounded faster over this window
Log scale — wide-divergence pair
IPSC PALI
IPSC vs PALI: by the numbers
- •PALI is the larger company ($261M vs $248M market cap).
- •Both run net losses; IPSC's is the smaller (-8.78% vs -6388.20% net margin).
Metrics side by side
Valuation
| Metric | IPSC | PALI |
|---|---|---|
| P/S ratio | N/A | 522.47 |
| P/B ratio | 1.07 | 2.15 |
Profitability
| Metric | IPSC | PALI |
|---|---|---|
| Gross margin | 88.00% | 0.00% |
| Operating margin | -13.78% | 0.00% |
| Net margin | -8.78% | -6388.20% |
| ROE | -47.25% | -26.24% |
| ROIC | -43.69% | -28.96% |
Growth (annualized)
| Metric | IPSC | PALI |
|---|---|---|
| Total return CAGR (5Y) | -42.05% | -76.02% |
Frequently asked
- How have IPSC and PALI total returns compared?
- Over the past 5 years, IPSC delivered -42.05% and PALI delivered -76.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.